Jan 15, 2015 7:00am EST Tonix Pharmaceuticals Commences Phase 2 Trial of TNX-102 SL in Post-Traumatic Stress Disorder
Jan 14, 2015 8:40am EST Tonix Pharmaceuticals to Present at the Noble Financial Annual Investor Conference
Jan 9, 2015 7:00am EST Tonix Pharmaceuticals Announces Clinical Progress on Potential Treatment for Headache
Jan 6, 2015 7:00am EST Tonix Pharmaceuticals Provides Clinical and Regulatory Update on its Continued Development of TNX-102 SL in Fibromyalgia
Oct 21, 2014 8:40am EDT Tonix Pharmaceuticals Receives IND Clearance for TNX-201 in Episodic Tension-Type Headache
Sep 29, 2014 6:00am EDT Tonix Pharmaceuticals Reports Top Line Results From Phase 2b BESTFIT Trial of TNX-102 SL in Patients With Fibromyalgia
